References
- Center for Disease Control. Update: acquired immunodeficiency syndrome (AIDS)—worldwide. MMWR 1988: 37(18): 286–8, 293–5
- Center for Disease Control. AIDS weekly survelliance report. 1989 Feb 20
- DeVita VT Jr, Broder S. Faucl AS, et al. Developmental therapeutics and the acquired immunodeficiency syndrome. Ann Intern Med 1987: 106(4): 568–81
- Fischl MA, Richman DD, Grieco MH, et al. The efficiency of azidothymidine [AZT) in the treatment of patients with AIDS and ADIS-related complex: a double-blind. placeb controlled trial. N Engl J Med 1987: 31(4): 185–91
- Azidothymidine for AIDS. Med Lett Drugs Ther 1986: 28(726): 107–9
- Hirsch MS. AIDS commentary: azidothymidine. J Infect Dis 1988: 157(3): 427–431
- Awe JR. Benefits. promise and limitations d zidovudine (AZT). COnsultant 1988: 29(11): 57–72
- Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine: follow-up of patients in a compassionate plea program. JAMA 1988: 260(20): 3009–15
- Jackson GG, Paul DA, Falk LA, et al. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT). Ann Intern Med 1988: 108(2): 175–80
- Schmitt FA, Bigley JW, McKinnis R, et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988: 319(24): 1573–8
- Fischl MA, Gottlieb MS. Managing patients on zidovudine therapy. HIV Dis Mgmt 1988: 2(2): 1–14
- Fischl MA, Gottlieb MS. Diagnosis and progression of disease. HIV Dis Mgmt 1988: 2(1): 1–22
- Pottage JC Jr, Benson CA, Spear JB, et al. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine. JAMA 1988: 260(20): 3045–8
- Hirsch MS. The rocky road to effective treatment of human immunodeficiency virus (HIV) Infection. Arm Intern Med 1989: 110(1): 1–3
- Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) In the treatment of patients with AIDS and AIDS-related complex: a double-blind. placebo-controlled trial. N Engl J Med 1987: 317(4): 192–7
- Walker RE, Parker RI, Kovacs JA, et al. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med 1988: 108(3): 372–6
- Herbert V, Hirschman S, Jacobson J. Lithium for zidovudine-induced neutropenia in AIDS. (Letter) JAMA 1988: 260(24): 3588
- Bessen LJ, Greene JB, Louie E, et al. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. (Letter) N Engl J Med 1988: 318(11): 708
- Spear JB, Kessler HA, Lehrman SN, et al. Zidovudine overdosage. Arm Intern Med 1988: 109(1): 76–77
- Helbert M, Robinson D, Peddle B, et al. Acute meningo-encephalitis on dose reduction of zidovudine. Lancet 1988: 1 (8597): 1249–52
- Fischl MA, Gottlieb MS. Cases and commentartes. HN Dis Mgmt 1988: 2(3): 4–15
- Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis cartnii pneumonitis. N Engl J Med 1987: 316(26): 1627–32
- Montgomery AB, Debs RJ, Luce JM, et al. Selective delivery of pentamidine to the lung by aerosol. Am Rev Resptr Dis 1988: 137(2): 477–8
- Balis FM, Pizzo PA, Murphy RF, et al. The pharmacokinetics of zidovudine administered by continuous Infusion in children. Arm Intern Med 1989: 110(4): 279–85